Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Immunol., 21 July 2025

Sec. Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1661243

Correction: Evaluation of a novel chemiluminescent immunoassay for autoantibody detection in pemphigus and bullous pemphigoid

Na Zhang&#x;Na Zhang1†Ming Wang&#x;Ming Wang2†Lili Hou&#x;Lili Hou1†Yanyu ZhangYanyu Zhang1Yan ZhaoYan Zhao1Luyang DuLuyang Du2Xiaoqing LiXiaoqing Li1Xia LiuXia Liu1Hongwei ZhouHongwei Zhou1Jiaxuan HaoJiaxuan Hao1Jing TianJing Tian3Qiuping YuQiuping Yu2Lixia LiLixia Li2Fangming ChengFangming Cheng4Hai-Zhou Zhou*Hai-Zhou Zhou1*
  • 1Department of Laboratory Diagnostics, The First Affiliated Hospital of Harbin Medical University, Harbin, China
  • 2Global Academic Department, Shenzhen YHLO Biotech Co., Ltd, Shenzhen, Guangdong, China
  • 3Dermatology, The First Affiliated Hospital of Harbin Medical University, Harbin, China
  • 4Reagent R&D Center, Shenzhen YHLO Biotech Co., Ltd, Shenzhen, Guangdong, China

A Correction on
Evaluation of a novel chemiluminescent immunoassay for autoantibody detection in pemphigus and bullous pemphigoid

By Zhang N, Wang M, Hou L, Zhang Y, Zhao Y, Du L, Li X, Liu X, Zhou H, Hao J, Tian J, Yu Q, Li L, Cheng F and Zhou H-Z (2025). Front. Immunol. 16:1576635. doi: 10.3389/fimmu.2025.1576635

Author Ming Wang was erroneously assigned to affiliation “Department of Pathology, University of Cambridge, Cambridge, United Kingdom”. This affiliation has now been removed and affiliation “Global Academic Department, Shenzhen YHLO Biotech Co., Ltd, Shenzhen, Guangdong, China” has now been added for author Ming Wang.

The conflict of interest statement has been correct to:

“Authors MW, LD, QY, LL and FC were employed by Shenzhen YHLO Biotech Co., Ltd.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.”

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: pemphigus, bullous pemphigoid, desmoglein, BP180, BP230, chemiluminescent immunoassay

Citation: Zhang N, Wang M, Hou L, Zhang Y, Zhao Y, Du L, Li X, Liu X, Zhou H, Hao J, Tian J, Yu Q, Li L, Cheng F and Zhou H-Z (2025) Correction: Evaluation of a novel chemiluminescent immunoassay for autoantibody detection in pemphigus and bullous pemphigoid. Front. Immunol. 16:1661243. doi: 10.3389/fimmu.2025.1661243

Received: 07 July 2025; Accepted: 09 July 2025;
Published: 21 July 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Zhang, Wang, Hou, Zhang, Zhao, Du, Li, Liu, Zhou, Hao, Tian, Yu, Li, Cheng and Zhou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Hai-Zhou Zhou, aGFpemhvdXpob3VAMTYzLmNvbQ==

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.